Cargando…
Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages via Inhibiting Expression of IRAK1-NF-κB Signaling Pathway
Jieduquyuziyin prescription (JP) has been used to treat systemic lupus erythematosus (SLE). Although the effectiveness of JP in the treatment of SLE has been clinically proven, the underlying mechanisms have yet to be completely understood. We observed the therapeutic actions of JP in MRL/lpr mice a...
Autores principales: | Ji, Lina, Fan, Xuemin, Hou, Xiaoli, Fu, Danqing, Bao, Jie, Zhuang, Aiwen, Chen, Sixiang, Fan, Yongsheng, Li, Rongqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372094/ https://www.ncbi.nlm.nih.gov/pubmed/32760274 http://dx.doi.org/10.3389/fphar.2020.01049 |
Ejemplares similares
-
Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway
por: Ji, Lina, et al.
Publicado: (2019) -
Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice
por: Liu, Jingqun, et al.
Publicado: (2022) -
Paeoniflorin Inhibits LPS-Induced Activation of Splenic CD4(+) T Lymphocytes and Relieves Pathological Symptoms in MRL/lpr Mice by Suppressing IRAK1 Signaling
por: Ji, Lina, et al.
Publicado: (2022) -
Jieduquyuzishen Prescription Attenuates Renal Fibrosis in MRL/lpr Mice via Inhibiting EMT and TGF-β1/Smad2/3 Pathway
por: Wu, Shan, et al.
Publicado: (2022) -
Self-Reactivity and the Expression of Memory Markers
Vary Independently in MRL-Mp+/+ and MRL-Mp-lpr/lpr
Mice
por: Smyth, Lesley, et al.
Publicado: (1992)